Final results of Phase 2 clinical trials show Jusvinza effectively treats post-acute and chronic Chikungunya symptoms
The final results of the Phase 2 clinical trials for Jusvinza treatment in patients recovering from Chikungunya, both in the post-acute and chronic stages of the disease, confirmed the hypothesis posed by the researchers: “It resolved the painful and inflammatory joint symptoms caused by this virus.”




